Search for: "Mylan Pharmaceuticals" Results 121 - 140 of 738
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
24 Jun 2010, 1:47 pm by Joseph Sano
Co., a case involving coverage for underlying complaints alleging antitrust violations and fraud in the marketing of generic pharmaceuticals. [read post]
30 Sep 2013, 4:50 am by Gene Quinn
Mark Lemley's Firm Files DJ Against Myriad in Northern California ----- Promise Not to Infringe Insufficient in ANDA Litigation ----- Licensing Deals Stall in Pharmaceutical Sector in First Half of 2013 ----- Mylan Settles with FTC over Agila Acquisition from Strides ----- Amgen and ShanghaiTech University Announce China R&D Center ----- Forest Laboratories sues over SAVELLA® generics ----- Teva Pharmaceutical scores patent cictory over Mylan on… [read post]
7 Jan 2008, 8:48 pm
Mylan Pharmaceuticals Inc. 1:07-cv-00177; filed December 28, 2007 in the Northern District of... [read post]
18 Oct 2016, 8:23 pm by Kate Howard
The petition of the day is: Mylan Pharmaceuticals Inc. v. [read post]
30 Mar 2016, 9:59 pm by Patent Docs
Mylan Laboratories Ltd. et al. 1:15-cv-00942; filed October 19, 2015 in the District Court of Delaware • Plaintiffs: Fresenius Kabi USA, LLC; Fresenius Kabi Deutschland GmbH • Defendants: Mylan Laboratories Ltd.; Mylan Inc.; Agila Specialties Inc.; Mylan Pharmaceuticals Inc. [read post]
27 Jun 2008, 6:35 am
Barr Pharmaceuticals Inc. and Mylan Inc. invalidated a patent (4,886,812) of Boehringer Ingelheim on Mirapex in D. [read post]
21 Feb 2006, 10:13 pm
The consolidated defendants (Mylan Laboratories Inc, Mylan Pharmaceuticals, Inc., UDL Laboratories, Inc., Alphapharm Pty. [read post]
1 Dec 2008, 3:33 am
Mylan Pharmaceuticals, Inc. et al.1:08-cv-00210; filed November 26, 2008 in the Northern District of West VirginiaEurand, Inc. et al. v. [read post]
30 Aug 2011, 5:18 am by Lawrence B. Ebert
The Mylan case is Teva Pharmaceuticals Industries Ltd. v. [read post]
25 Jul 2011, 1:34 am by Lawrence B. Ebert
Mylan Inc. and Momenta Pharmaceuticals Inc. have each challenged Teva's patents on Copaxone.Separately, note the postGeneric drugs have slower approval route than new ones, backlogged by FDA staff shortage [read post]
27 Jul 2018, 6:00 am by Kyle Kroll
Mylan Pharmaceuticals, Inc., 18-1638 (Fed. [read post]
22 Jan 2019, 6:15 am by Joseph Robinson
Mylan Pharmaceuticals petitioned for IPR of the ‘650 patent alleging certain claims were obvious. [read post]
22 Mar 2007, 9:57 pm
In the Federal Circuit opinion released today, a unanimous three-judge panel determined that claims 1-3 of the '353 patent, directed to amlodipine besylate and pharmaceutical and tablet formulations thereof, are invalid as obvious. [read post]
12 Feb 2019, 10:15 am by Robert Schaffer & Joseph Robinson
The Federal Circuit first visited the issue of whether three petitioners—Mylan Pharmaceuticals, Breckenridge Pharmaceuticals, and Alembic Pharmaceuticals, all of whom were sued for infringement of the patent more than one year prior to the institution of the... [read post]